Profusa To Trade On Nasdaq Capital Market, Effective May 15
Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives Intended To Maximize Shareholder Value And Support Commercial, Regulatory And Platform-Expansion Initiatives
What's Going On With Profusa Stock Tuesday?
Profusa Stock Soars On Deal Targeting Multi Billion Precision Diagnostics Space
Profusa shares are trading higher after company announced it will acquire the PanOmics multi-omics diagnostics platform from BioInsights LLC for approximately $30 million in stock.
Profusa Plans $30M Deal to Expand Into Diagnostics With PanOmics Platform
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
Profusa To Withdraw S-1 Registration Statement to Pursue More Focused Offering
Profusa shares are trading lower. The company announced it received several purchase orders for the Lumee tissue oxygen monitoring system and raised its FY26 revenue guidance.
Profusa Receives Multiple Purchase Orders From Lumee, Raises FY 2026 Revenue Guidance From $0.5M-$2.0M To $1.5M-$3.0M
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
Profusa To Offer 5,102,040 Shares At $2.94/Share
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
Profusa To Collaborate With Mayo Clinic On New Investigation Of Profusa Tech For Clinical Applications
Profusa Partners With Mayo Clinic Over Clinical Applications Of Profusa's Oxygen Monitoring Technologies To Develop, Commercialize New Products
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Profusa Announces 1-for-75 Reverse Stock Split
Profusa shares are trading lower after the company announced a 1-for-75 reverse stock split.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.